01
Cash & equivalents increased 111.5%
Cash & equivalents changed +111.5% from the comparable as-filed period.
$22.3M→$47.1MComparable → current
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTFRACTYL HEALTH, INC.'s latest supported as-filed period reports net income of -$25.5M, 8.4% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +111.5% from the comparable as-filed period.
Net income changed +8.4% from the comparable as-filed period.
Operating income changed +26.8% from the comparable as-filed period.
Research & development changed -34.7% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
GUTS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-342345SEC ↗8-KAug 10, 2026Period Aug 10, 20260001193125-26-342343SEC ↗8-KJul 15, 2026Period Jul 15, 20260001193125-26-303948SEC ↗4Jun 15, 2026Period Jun 12, 20260001193125-26-271386SEC ↗8-KJun 11, 2026Period Jun 10, 20260001193125-26-267897SEC ↗4Jun 11, 2026Period Jun 10, 20260001193125-26-267851SEC ↗4Jun 11, 2026Period Jun 10, 20260001193125-26-267849SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 12, 2026Filed Jun 15, 2026 | Royan AjayDirector | Open Market PurchaseDirect | 23,000 | $1 | $19,596 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Selling, general & administrative changed +7.2% from the comparable as-filed period.
Stock-based compensation changed +39.8% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-267847